Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery
- 234 Downloads
Clinical outcome of patients with oral cavity squamous cell carcinoma (OSCC) and contralateral neck recurrence (CLNR) remains poor. We sought to identify factors associated with CLNR and incorporate them into a risk stratification scheme. Between January 1996 and June 2006, a total of 913 consecutive OSCC patients treated by radical surgery were investigated. Postoperative adjuvant therapy was performed in the presence of pathological risk factors. The duration of follow-up was at least 24 months in all surviving patients. Outcome measures were the 5-year CLNR and overall survival rates. In the entire study cohort, the 5-year CLNR rate was 7% (55/913). Specifically, it was 18% (17/132) in patients with local recurrence (LR), and 5% (38/781) in those without (P = 0.0002). In multivariate analysis, extracapsular spread (ECS) was the only independent risk factor for CLNR in patients with LR. Tumor subsite, poor differentiation, and presence of pN + disease were significant predictors of CLNR in patients without LR. We identified two groups of patients with high CLNR rates. The first group consisted of patients with ECS at the initial diagnosis and LR. The second group consisted of subjects with tongue cancer without LR harboring at least two risk factors. We conclude that, in patients who achieved local control, postoperative contralateral neck treatment is recommended for subjects with tongue cancer and at least two risk factors. Once LR occurs, contralateral neck treatment is recommended in patients with ECS.
KeywordsNeck Dissection Tongue Cancer Oral Cavity Cancer Oral Cavity Squamous Cell Carcinoma Neck Recurrence
This study was supported by grants NMRPG160031, CMRPG361051, and CMRPG370061 from the Chang Gung Memorial Hospital.
Conflicts of interest statement
The authors indicated no potential conflicts of interest.
Conception and design: C.T. Liao, T.C. Yen.
Funding support: NMRPG160031, CMRPG361051, and CMRPG370061.
Administrative support: T.C. Yen.
Provision of study materials or patients: C.T. Liao, S.F. Huang, I.H. Chen, J.T.C. Chang, H.M. Wang, S.H. Ng, C. Hsueh, L.Y. Lee, C.H. Lin, A.J. Cheng, T.C. Yen.
Collection and assembly of data: C.T. Liao, S.F. Huang, I.H. Chen, J.T.C. Chang, H.M. Wang, S.H. Ng, C. Hsueh, L.Y. Lee, C.H. Lin, I.H. Chen, S.F. Huang, A.J. Cheng, T.C. Yen.
Data analysis and interpretation: C.T. Liao, T.C. Yen.
Manuscript writing: C.T. Liao, T.C. Yen.
Final approval of manuscript: C.T. Liao, T.C. Yen.
- 11.Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.Google Scholar
- 12.Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, editors. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.Google Scholar
- 16.Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999–1004.CrossRefPubMedGoogle Scholar
- 18.Taiwan cancer registry, 2008 annual report. Available from: http://crs.cph.ntu.edu.tw/. Accessed October 27, 2008.